Acquisition of Vilebrequin - (Detail Textuals)	6 Months Ended		1 Months Ended			1 Months Ended
	Jul. 31, 2013 USD ($) Country	Jan. 31, 2013 USD ($)	Aug. 07, 2012 Vilebrequin USD ($)	Aug. 07, 2012 Vilebrequin EUR (€)	Jul. 31, 2013 Vilebrequin USD ($)	Aug. 07, 2012 Vilebrequin Franchise Rights USD ($)	Aug. 07, 2012 Vilebrequin Customer Relationships USD ($)	Aug. 07, 2012 Vilebrequin Trademarks USD ($)	Aug. 07, 2012 Vilebrequin Unsecured promissory notes
Business Acquisition [Line Items]
Business acquisition agreement consideration in cash			$ 87,573,000	€ 70,500,000
Business acquisition, liabilities incurred			18,633,000	15,000,000
Business acquisition, note interest payable rate									5.00%
Maturity date of note			Dec. 31, 2017	Dec. 31, 2017
Business acquisition, contingent future payment			27,900,000	22,500,000
Contingent consideration payable	5,711,000	5,787,000	5,452,000		5,700,000
Exchange rate on the date of acquisition			$ 1.242	€ 1.000
Products sold in number of countries	50
Total consideration paid by the company in business acquisition			111,658,000
Business acquisition, acquired goodwill and intangible assets			95,600,000
Acquired indefinite lived intangible asset amount								58,700,000
Acquired finite lived intangible asset amount						$ 7,500,000	$ 2,600,000
Acquired finite lived intangible assets, estimated useful life						14 years	8 years